UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Daewoong nurtures foreign employee abilities at company workshop
Daewoong Pharmaceutical대웅제약 (CEO Lee Jong-wook이종욱) said Tuesday it held a w...
by Marian Chu
|
2017-07-18 10:59
라인
Bayer gets domestic approval for liver cancer drug
Bayer’s second-line treatment for liver cancer, Stivarga, has gained the Ko...
by Marian Chu
|
2017-07-17 12:28
라인
Dong-A Pharm 2nd-largest maker of quasi-medicinal products
Bacchus-D, a nutritional tonic made by Dong-A Pharm, became the quasi-medic...
by Lee Hye-seon
|
2017-07-14 16:16
라인
Chong Kun Dang chairman apologizes for repeated slurs against drivers
Lee Jang-han, chairman of pharmaceutical company Chong Kun Dang종근당, issued ...
by Marian Chu
|
2017-07-14 11:06
라인
Ocular Therapeutix under probe for faulty manufacture
A U.S. law firm is looking into investor claims regarding Ocular Therapeuti...
by Marian Chu
|
2017-07-13 10:42
라인
Ministry approves 1st domestic gene therapy product
The Ministry of Food and Drug Safety said Wednesday it granted approval to ...
by Marian Chu
|
2017-07-12 11:42
라인
Jeil Pharmaceutical gets European approval for antibiotics
The European Directorate for the Quality of Medicines (EDQM) has approved J...
by Marian Chu
|
2017-07-12 10:55
라인
How do clinical trials affect stock prices of pharmaceutical giants?
Bristol-Myers Squibb (BMS) and Merck, Sharp and Dohme (MSD), a subsidiary o...
by Marian Chu
|
2017-07-12 10:48
라인
Castleman’s disease patients suffer from high drug prices
Recently, some therapies for a small number of patients, including Ibrance ...
by Park Gi-taek
|
2017-07-11 17:00
라인
BMS extends use of Sprycel to treat leukemia patients
The U.S. Food and Drug Administration Monday approved Bristol-Myers Squibb’...
by Marian Chu
|
2017-07-11 10:36
라인
Ildong’s 1st new drug to get conditional insurance benefits
The Pharmaceutical Benefits Committee has approved the chronic hepatitis B ...
by Lee Hye-seon
|
2017-07-10 18:26
라인
Are made-in-Korea Botox products smuggled into China?
The Chinese government has never approved Korean “Botulinum toxin” products...
by Nam Doo-hyun
|
2017-07-10 16:25
라인
People with experiences more positive about clinical trials
People who have experienced clinical trials for medicines have a more posit...
by Lee Hye-seon
|
2017-07-07 16:41
라인
Breast cancer therapy Ibrance likely to get insurance benefit
Pfizer’s breast cancer therapy Palbociclib, better known as Ibrance, is lik...
by Nam Doo-hyun
|
2017-07-07 14:26
라인
Bristol-Myers Squibb’s anti-arthritis drug wins FDA approval
Bristol-Myers Squibb said Thursday the U.S. Food and Drug Administration ha...
by Marian Chu
|
2017-07-07 09:59
라인
Korea’s medical supplies market grew to $17.3 billion last year
The nation’s market of medicine and medical supplies increased 12.9 percent...
by Marian Chu
|
2017-07-06 16:49
라인
Will patent lawsuit results affect market of Lyrica Capsule?
Pfizer partially won a legal battle over Lyrica Cap. with 13 Korean pharmac...
by Lee Hye-seon
|
2017-07-06 15:04
라인
Korea one of the first countries to issue warnings on finasteride
Korea has become one of the first countries to warn the public of the depre...
by Marian Chu
|
2017-07-05 18:22
라인
Boryung, Kiara sign contract for high blood pressure drug
Boryung Pharmaceuticals said Tuesday it had signed a memorandum of understa...
by Constance Williams
|
2017-07-05 17:15
라인
LG Chem’s antidiabetic hits monthly sale of $5.2 million in May
LG Chem’s diabetes drug Zemiglo has hit a sales milestone of 6 billion won ...
by Marian Chu
|
2017-07-05 10:40
-
이전
111
112
113
114
115
116
117
118
119
120
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top